Demographic Factors, Medication Adherence, and Post-transplant Health Outcomes: A Longitudinal Multilevel Modeling Approach

J Clin Psychol Med Settings. 2024 Mar;31(1):163-173. doi: 10.1007/s10880-023-09970-4. Epub 2023 Aug 17.

Abstract

Few studies in pediatric solid organ transplantation have examined non-adherence to immunosuppressive medication over time and its associations with demographic factors and post-transplant outcomes including late acute rejection and hospitalizations. We examined longitudinal variation in patient Medication Level Variability Index (MLVI) adherence data from pediatric kidney, liver, and heart transplant recipients. Patient and administrative data from the United Network for Organ Sharing were linked with electronic health records and MLVI values for 332 patients. Multilevel mediation modeling indicated comparatively more variation in MLVI values between patients than within patients, longitudinally, over 10 years post transplant. MLVI values significantly predicted late acute rejection and hospitalization. MLVI partially mediated patient factors and post-transplant outcomes for patient age indicating adolescents may benefit most from intervention efforts. Results demonstrate the importance of longitudinal assessment of adherence and differences among patients. Efforts to promote medication adherence should be adapted to high-risk patients to increase likelihood of adherence.

Keywords: Longitudinal; MLVI; Medication adherence; Pediatric organ transplantation.

MeSH terms

  • Adolescent
  • Child
  • Demography
  • Humans
  • Immunosuppressive Agents* / adverse effects
  • Liver Transplantation*
  • Medication Adherence

Substances

  • Immunosuppressive Agents